OMGCX | RPMGX | OMGCX / RPMGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 32 years | - |
Gain YTD | 4.631 | 3.239 | 143% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.2B | 31.4B | 39% |
Annual Yield % from dividends | 0.00 | 0.05 | - |
Returns for 1 year | 5.78 | 4.60 | 126% |
Returns for 3 years | -5.87 | -8.96 | 66% |
Returns for 5 years | 7.00 | 9.06 | 77% |
Returns for 10 years | 24.13 | 37.01 | 65% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 25.49 | -0.06 | -0.22% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
CWB | 80.77 | -0.42 | -0.52% |
SPDR® Blmbg Convert Secs ETF | |||
LEAD | 69.63 | -0.55 | -0.78% |
Siren DIVCON Leaders Dividend ETF | |||
FDM | 70.89 | -0.83 | -1.16% |
First Trust Dow Jones Sel MicroCap ETF | |||
REM | 21.88 | -1.26 | -5.45% |
iShares Mortgage Real Estate Capped ETF |